Matthijs van Thiel de Vries

Matthijs has over 11 years of transaction experience and specialises in mergers and acquisitions in the field of Healthcare and Life Sciences. He has extensive knowledge and experience in advising on (international) transactions for strategic parties, entrepreneurs, healthcare organisations and private equity. Recently, he advised on, amongst others, the sale of Tromp Medical to Capital A, the sale of Opdidakt to MentaalBeter, the sale of Fysius to AAC Capital, the sale of Luscii to Omron, the sale of Medlon to Unilabs and the sale of Penders to Foreman Capital.